Value of new quinolones in the treatment and prophylaxis of infectious diseases: introductory remarks.
Wolfson
J S
JS
Medical Services, Massachusetts General Hospital, Boston 02114.
Murray
B E
BE
D055598:Chemical Phenomena; D002621:Chemistry; D004250:DNA Topoisomerases, Type II / Q000502:physiology; D004926:Escherichia coli / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D015363:Quinolones / Q000032:analysis / Q000145:classification / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000517:prevention & control; D059005:Topoisomerase II Inhibitors; D014552:Urinary Tract Infections / Q000517:prevention & control
D015363:Quinolones; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II